Nvidia doesn’t have a monopoly in AI — though it sure seems that way
Pricing power and lack of competition are driving Nvidia’s growth, but rivals are gaining traction.
Pricing power and lack of competition are driving Nvidia’s growth, but rivals are gaining traction.
The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting...
Investors are abandoning bets that the Federal Reserve will cut interest rates three times in 2024, removing a critical safety net for stocks.
Rent the Runway Inc. on Wednesday said it expected breakeven free cash flow this year, following cost cuts and signs of a revival in shoppers’...
Shares of Honest Co. fell Wednesday after it lost rights to use the name and likeness of founder Jessica Alba.
Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue...
The aerospace giant’s self-inflicted woes hold broader lessons on how to run a company.
Stocks fall, Treasury yields rise after a hotter-than-expected CPI reading.
Nvidia’s $2.2 trillion market cap, once seen as “unfathomable,” could head even higher, according to Morgan Stanley.